Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases

• Главные авторы: Nicola Imperatore (Автор), Fabiana Castiglione (Автор), Antonio Rispo (Автор), Anna Sessa (Автор), Nicola Caporaso (Автор), Filomena Morisco (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2017-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: In the last years, inflammatory bowel disease (IBD) and hepatitis C virus (HCV) infection management has completely changed. However, the role of direct-acting antivirals (DAAs) and the correct timing of antiviral drugs administration in IBD patients needing biologics has not been evalua...